9. Woodrow CJ, Haynes RK, Krishna S (2005) Artemisinins. Postgrad Med J 81: 71–78. 10. Rosenthal PJ (2008) Artesunate for the treatment of severe falciparum malaria. N Engl JMed 358: 1829–1836. 11. Krishna S, Bustamante L, Haynes RK, Staines HM (2008) Artemisinins: their growing importance in medicine. Trends Pharmacol Sci 29: 520–527. 12. Hou JM, Wang DS, Zhang RW, Wang H (2008) Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 14: 5519–5530. 13. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, et al. (2008) The antiviral activities of artemisinin and artesunate. Clin Infect Dis 47: 804–811. 14. Xu H, He Y, Yang X, Liang L, Zhan Z, et al. (2007) Anti-malarial agent artesunate inhibits TNF-a-induced production of proinflammatory cytokines via inhibition of NF-kB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 46: 920–926. 15. Li WD, Dong YJ, Tu YY, Lin ZB (2006) Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-a and blocking the signaling pathway NF-kB translocation. Int Immunopharmacol 6: 1243–1250. 16. Li B, Zhang R, Li J, Zhang LH, Ding GF, et al. (2008) Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kB activation. Int Immunopharmacol 8: 379–389. 17. Wang ZJ, Qiu J, Guo TB, Liu A, Wang Y, et al. (2007) Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis. J Immunol 179: 5958–5965. 18. Thomas M, Edwards MJ, Sawicka E, Duggan N, Hirsch E, et al. (2009) Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation. Immunology 126: 413–422. 19. Fruman DA, Bismuth G (2009) Fine tuning the immune response with PI3K. Immunol Rev 228: 253–272. 20. Kim MS, Radinger M, Gilfillan AM (2008) The multiple roles of phosphoino- sitide 3-kinase in mast cell biology. Trends Immunol 29: 493–501. 21. Nashed BF, Zhang TT, Al-Alwan M, Srinivasan G, Halayko AJ, et al. (2007) Role of the phosphoinositide 3-kinase p110d in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 37: 416–424. 22. Takeda M, Ito W, Tanabe M, Ueki S, Kato H, et al. (2009) Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase c-deficient mice. J Allergy Clin Immunol 123: 805–812. 23. Lim DH, Cho JY, Song DJ, Lee SY, Miller M, et al. (2009) PI3K c-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol-Lung Cell Mol Physiol 296: L210–L219. 24. Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, et al. (2002) PI3K- mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 3: 875–881. 25. Turner J, Jones CE (2009) Regulation of mucin expression in respiratory diseases. Biochem Soc Trans 37: 877–881. 26. Suresh V, Mih JD, George SC (2007) Measurement of IL-13-induced iNOS- derived gas phase nitric oxide in human bronchial epithelial cells. Am J Respir Cell Mol Biol 37: 97–104. 27. Zhou BH, Comeau MR, De Smedt T, Liggitt HD, Dahl ME, et al. (2005) Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6: 1047–1053. 28. Wakashin H, Hirose K, Maezawa Y, Kagami SI, Suto A, et al. (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J RespirCrit Care Med 178: 1023–1032. 29. Kearley J, Buckland KF, Mathie SA, Lloyd CM (2009) Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 179: 772–781. 30. Yang CJ, Shen CR, Kuo ML, Shen CN, Liu YK (2008) RNA interference- mediated inhibition of acidic mammalian chitinase suppresses OVA-sensitized allergic asthma. Clin Immunol 127: S44–S45. 31. Zhao J, Zhu H, Wong CH, Leung KY, Wong WSF (2005) Increased lungkine and chitinase levels in allergic airway inflammation: A proteomics approach. Proteomics 5: 2799–2807. 32. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, et al. (2007) A chitinase- like protein in the lung and circulation of patients with severe asthma. N Engl J Med 357: 2016–2027. 33. Kelly M, Hwang JM, Kubes P (2007) Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 120: 3–10. 34. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, et al. (2004) Cell type- specific expression of the IkB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kB activation. J BiolChem 279: 1615–1620. 35. Burgel PR, Nadel JA (2008) Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 32: 1068–1081. Artesunate Attenuates Asthma 36. Tamaoka M, Hassan M, McGovern T, Ramos-Barbon D, Jo T, et al. (2008) The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J 32: 1213–1223. 37. Zhen GH, Park SW, Nguyenvu LT, Rodriguez MW, Barbeau R, et al. (2007) IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production. Am J Respir Cell Mol Biol 36: 244–253. 38. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, et al. (2009) House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15: 410–416. 39. Muller T, Vieira RP, Grimm M, Durk T, Cicko S, et al. (2010) A potential role for P2X7R in allergic airway inflammation in mice and humans. Am J Respir Cell Mol Biol 44: 456–464. 40. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, et al. (2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111: 1083–1092. 41. Myou S, Leff AR, Myo S, Boetticher E, Tong JK, et al. (2003) Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med 198: 1573–1582. 42. Duan W, Datiles A, Leung BP, Vlahos CJ, Wong WSF (2005) An anti- inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5: 495–502. 43. Lee KS, Lee HK, Hayflick JS, Lee YC, Puri KD (2006) Inhibition of phosphoinositide 3-kinase dattenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 20: 455–465. 44. Doukas J, Eide L, Stebbins K, Racanelli-Layton A, Dellamary L, et al. (2009) Aerosolized phosphoinositide 3-kinase c/dInhibitor TG100-115 [3-[2,4-Diami- no-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. J Pharmacol Exp Ther 328: 758–765. 45. Fujitani Y, Trifilieff A (2003) In vivo and in vitro effects of SAR 943, a rapamycin analogue, on airway inflammation and remodeling. Am J Respir Crit Care Med 167: 193–198. 46. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, et al. (2005) IkB kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 172: 962–971. 47. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD (2003) Interleukin-4 and interleukin-13 signaling connections maps. Science 300: 1527–1528. 48. Sano M, Leff AR, Myou S, Boetticher E, Meliton AY, et al. (2005) Regulation of interleukin-5-induced b2-integrin adhesion of human eosinophils by phospho- inositide 3-kinase. Am J Respir Cell Mol Biol 33: 65–70. 49. Meyer-Hoffert U, Lezcano-Meza D, Bartels J, Montes-Vizuet AR, Schroder JM, et al. (2003) Th2-and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells. Int Arch Allergy Immunol 131: 264–271. 50. Kumar A, Takada Y, Boriek AM, Aggarwal BB (2004) Nuclear factor-kB: its role in health and disease. J Mol Med 82: 434–448. 51. Webb DC, McKenzie ANJ, Foster PS (2001) Expression of the Ym2 lectin- binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction - Identification of a novel allergy-associated protein. J Biol Chem 276: 41969–41976. 52. Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G (2004) Nitric oxide in health and disease of the respiratory system. Physiol Rev 84: 731–765. 53. Lane C, Knight D, Burgess S, Franklin P, Horak F, et al. (2004) Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 59: 757–760. 54. Sakai K, Suzuki H, Oda H, Akaike T, Azuma Y, et al. (2006) Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage - Critical dimerization of inducible nitric-oxide synthase. J Biol Chem 281: 17736–17742. 55. Halayko AJ, Kartha S, Stelmack GL, McConville J, Tam J, et al. (2004) Phophatidylinositol-3 kinase/mammalian target of rapamycin/p70S6K regu- lates contractile protein accumulation in airway myocyte differentiation. Am J Respir Cell Mol Biol 31: 266–275. 56. Zhou LM, Goldsmith AM, Bentley JK, Jia Y, Rodriguez ML, et al. (2005) 4E- binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 33: 195–202. 57. Farghaly HSM, Blagbrough IS, Medina-Tato DA, Watson ML (2008) Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110 d-dependent mechanism. MolPharmacol 73: 1530–1537. 58. Bao Z, Guan SP, Cheng C, Wu SL, Wong SH, et al. (2009) A Novel Antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kB pathway. Am J Respir Crit Care Med 179: 657–665. PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e20932